Certus builds "smart" endovascular catheters that are designed to optimize blood pressure for patients suffering from catastrophic illnesses. The initial focus of the product within the civilian market will be for patients suffering from a stroke, cardiac arrest, and hemorrhage. Certus has been built on over $15M in non-dilutional funding to date.